This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nickells, J.
Right arrow Articles by Chambers, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickells, J.
Right arrow Articles by Chambers, T. J.

 Previous Article  |  Next Article 

Journal of Virology, December 2008, p. 12510-12519, Vol. 82, No. 24
0022-538X/08/$08.00+0     doi:10.1128/JVI.00458-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model{triangledown}

Janice Nickells, Maria Cannella, Deborah A. Droll, Yan Liang, William S. M. Wold, and Thomas J. Chambers*

Department of Molecular Microbiology and Immunology, Doisy Research Center, St. Louis University School of Medicine, 1100 South Grand Boulevard, St. Louis, Missouri 63104

Received 2 March 2008/ Accepted 25 September 2008

A molecular clone of yellow fever virus (YFV) strain 17D was used to identify critical determinants of mouse neuroinvasiveness previously localized to domain III of the neuroadapted SPYF-MN virus envelope protein. Three candidate virulence substitutions (305F->V, 326K->E, and 380R->T) were individually evaluated for their roles in this phenotype in a SCID mouse model. The virus containing a glutamic acid residue at position 326 of the envelope protein (326E) caused rapidly lethal encephalitis, with a mortality rate and average survival time resembling those of the parental SPYF-MN virus. Determinants at positions 380 (380T) and 305 (305V) did not independently affect neuroinvasiveness. Testing a panel of viruses with various amino acid substitutions at position 326 revealed that attenuation of neuroinvasiveness required a positively charged residue (lysine or arginine) at this position. Molecular-modeling studies suggest that residues 326 and 380 contribute to charge clusters on the lateral surface of domain III that constitute putative heparin binding sites, as confirmed by studies of heparin inhibition of plaque formation. The neuroinvasiveness of YFVs in the SCID model correlated inversely with sensitivity to heparin. These findings establish that residue 326 in domain III of the E protein is a critical determinant of YFV neuroinvasiveness in the SCID mouse model. Together with modeling of domain III from virulent YFV strains, the data suggest that heparin binding activity involving lysine at position 326 may be a modulator of YFV virulence phenotypes.


* Corresponding author. Mailing address: Department of Molecular Microbiology and Immunology, Doisy Research Center, St. Louis University School of Medicine, 1100 South Grand Blvd., St. Louis, MO 63104. Phone: (314) 977-8711. Fax: (314) 977-8717. E-mail: thomas_chambers2{at}merck.com

{triangledown} Published ahead of print on 8 October 2008.


Journal of Virology, December 2008, p. 12510-12519, Vol. 82, No. 24
0022-538X/08/$08.00+0     doi:10.1128/JVI.00458-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Anez, G., Men, R., Eckels, K. H., Lai, C.-J. (2009). Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques. J. Virol. 83: 10384-10394 [Abstract] [Full Text]